J
Jean-Jacques Grob
Researcher at Aix-Marseille University
Publications - 369
Citations - 58038
Jean-Jacques Grob is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Medicine & Melanoma. The author has an hindex of 71, co-authored 310 publications receiving 45788 citations. Previous affiliations of Jean-Jacques Grob include University of Sydney.
Papers
More filters
Journal ArticleDOI
Tumor-specific circulating cell-free DNA (cfDNA) BRAF mutations (muts) to predict clinical outcome in patients (pts) treated with the BRAF inhibitor dabrafenib (GSK2118436).
Georgina V. Long,Paolo A. Ascierto,Jean-Jacques Grob,Omid Hamid,Richard F. Kefford,Richard F. Kefford,Céleste Lebbé,David R. Minor,Antoni Ribas,Dirk Schadendorf,Leslie A. Fecher,Uwe Trefzer,Nikita Arya,Robert C. Gagnon,Vicki L. Goodman,Anne Siegfried,Jolly Mazumdar,Anne-Marie Martin +17 more
TL;DR: Evaluation of efficacy, safety and tolerability of dabrafenib in BRAF V600E/K mut+ metastatic melanoma pts.
Journal Article
[Therapy algorithm for cutaneous T-cell lymphomas].
Hervé Bachelez,Martine Bagot,Marie Beylot-Barry,Alain Claudy,Florent Grange,Jean-Jacques Grob,Olivier Dereure,Brigitte Dréno,Michel D'Incan,Liliane Laroche,Roland Viraben,Groupe d'Experts +11 more
Journal Article
Is systematic excision of small congenital nevus recommended
Proceedings ArticleDOI
Abstract CT188: 5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma
Caroline Robert,Jacob Schachter,Georgina V. Long,Ana Arance,Jean-Jacques Grob,Laurent Mortier,Adil Daud,Matteo S. Carlino,Catriona M. McNeil,Michal Lotem,James Larkin,Paul Lorigan,Bart Neyns,Christian U. Blank,Omid Hamid,Teresa M. Petrella,James R. Anderson,Clemens Krepler,Scott J. Diede,Antoni Ribas +19 more
TL;DR: Pembro continued to show improved OS vs ipi in 5-year follow-up of pts with advanced melanoma with 43.2% estimated to be alive at 5 years versus 33.0% with ipi.
Journal ArticleDOI
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
Perrine Rousset,Stéphane Dalle,Laurent Mortier,Olivier Dereure,Sophie Dalac,Caroline Dutriaux,Marie-Thérèse Leccia,D. Legoupil,Florence Brunet-Possenti,Julie De Quatrebarbes,Jean-Jacques Grob,Philippe Saiag,Eve Maubec,P.-E. Stoebner,Florence Granel-Brocard,Jean-Philippe Arnault,Clara Allayous,Bastien Oriano,Céleste Lebbé,Henri Montaudié +19 more
TL;DR: In this article , the efficacy and safety of systemic treatments in patients with advanced melanoma compared to patients with stage-matched melanoma of known cutaneous primary (cMKP) were investigated.